ReviewNeuroimaging findings in frontotemporal lobar degeneration spectrum of disorders
Introduction
Frontotemporal lobar degeneration (FTLD) represents the second most common early onset neurodegenerative dementia (Rabinovici and Miller, 2010). FTLD is a clinically and pathologically heterogeneous spectrum of disorders, which encompasses distinct clinical syndromes: the behavioural variant of frontotemporal dementia (bvFTD), and the language variant (Rabinovici and Miller, 2010). bvFTD presents with marked changes in personality and behaviour (Neary et al., 1998), and, pathologically, is associated with all the three major FTLD pathologies, characterised by abnormal cellular inclusions containing either tau, TAR DNA-binding protein 43 (TDP-43), or fused in sarcoma (FUS) protein (Mackenzie et al., 2010). In the language variant, known as primary progressive aphasia (PPA), a prominent, isolated language deficit is the dominant feature during the initial phase of the disease (Mesulam, 2001). Distinct profiles of language impairment define the three clinical phenotypes of PPA (Gorno-Tempini et al., 2011): the non-fluent/agrammatic (for convenience hereafter called as non-fluent), characterised by agrammatism in language production and effortful speech with motor speech deficits; the semantic, characterised by progressive loss of knowledge about words and objects in the context of relatively preserved fluency of speech; and the logopenic, characterised by impaired naming and repetition in the context of spared syntactic and motor speech abilities. The non-fluent variant is most commonly associated with tau pathology (Josephs et al., 2006, Knibb et al., 2006), and the semantic with a TDP-43 proteinopathy (Grossman et al., 2007b, Hodges et al., 2004, Mesulam et al., 2008). Alzheimer’s disease (AD) is the most likely underlying pathology of the more controversial logopenic variant, although FTLD with TDP-43 immunoreactive inclusions (FTLD-TDP) changes can also be found (Josephs et al., 2008, Mesulam et al., 2008).
In the last few years, neuroimaging has contributed to the phenotypic characterisation of FTLD. The most commonly used neuroimaging approaches to assess FTLD are structural magnetic resonance imaging (MRI) and functional molecular techniques, i.e., single photon-emission computed tomography (SPECT) and positron emission tomography (PET). Structural MRI showed that each clinical syndrome is associated with a specific pattern of focal atrophy and is routinely used in the diagnostic work up of FTLD. SPECT allows to study cerebral perfusion with compounds such as the [99mTc]-hexamethylpropyleneamine oxime (HMPAO). PET, most frequently used with [18F]-fluorodeoxyglucose (FDG), provides estimates of cerebral metabolism. Overall, functional neuroimaging techniques offer a window on brain states relative to structural imaging or even in the absence of structural brain abnormalities.
Recent years have also witnessed impressive advances in the development of novel imaging approaches, which, with varying degrees of success, had improved our ability to diagnose and understand the pathophysiology of the disease. Diffusion tensor (DT) MRI allows to measure the random diffusional motion of water molecules and, thus, provides quantitative indices of the structural and orientational features of central nervous system tissues (Pierpaoli et al., 1996). Alterations in the brain microstructure associated with FTLD have the potential to modify water diffusion characteristics, which can be reflected in increased mean diffusivity (MD) and reduced fractional anisotropy (FA) values. The PET ligand [11C]-labelled Pittsburgh compound-B (PIB) binds specifically to fibrillar amyloid β (Aβ) (Klunk et al., 2004). The ability to image Aβ may allow distinction of FTLD from AD with a greater accuracy than that of other structural and functional imaging techniques. Given the costs, limited availability and relative invasiveness of FDG PET, functional MRI (fMRI) is likely to be an useful tool for detecting alterations in brain function that may be present very early in the course of FTLD. In particular, resting state (RS) fMRI has proved to be a new tool for mapping large-scale neural network function and dysfunction in neurodegenerative diseases (Greicius et al., 2004).
This article reviews comprehensively the state-of-the-art of neuroimaging in the study of FTLD spectrum of disorders, and envisages which will be new neuroimaging biomarkers that could improve the in vivo detection of the underlying pathology. This will be central in the design of treatment trials of new drugs targeting the pathological processes associated with FTLD, which are likely to emerge in the near future.
Section snippets
The pattern of brain atrophy
Structural MRI studies showed that bvFTD presents with a combination of frontal and anterior temporal cortical atrophy, usually asymmetrical (Boccardi et al., 2005, Du et al., 2007, Perry et al., 2006, Richards et al., 2009, Rosen et al., 2002, Seeley et al., 2008, Whitwell et al., 2009) (Fig. 1A). Such an atrophy pattern can be readily appreciated on coronal MRI scans. Nevertheless, an apparently normal MRI at visual inspections does not exclude a diagnosis of bvFTD, because tissue loss can be
Brain perfusion and glucose metabolism
In bvFTD, patterns of hypoperfusion and hypometabolism in frontal, insular, and anterior temporal cortices have been reported (Fig. 10) (Charpentier et al., 2000, Diehl et al., 2004, Franceschi et al., 2005, Ishii et al., 1998, Jeong et al., 2005, Le Ber et al., 2006, Salmon et al., 2003, Sjogren et al., 2000, Varma et al., 2002). The regions mostly impaired are the medial frontal cortex, followed by the frontolateral and anterior temporal cortices. Milder metabolic abnormalities often involve
Conclusions and future perspectives
Despite each FTLD variant is associated with characteristic behavioural and/or linguistic features, the fact that they harbour different underlying pathological processes renders the diagnostic work up of these patients a highly challenging task. However, the detection of distinct patterns of atrophy on structural MRI and functional abnormalities on SPECT and PET scans has been shown to contribute at establishing a correct diagnosis of FTLD (Gorno-Tempini et al., 2011, Neary et al., 1998,
References (143)
- et al.
Dementia induces correlated reductions in white matter integrity and cortical thickness: A multivariate neuroimaging study with sparse canonical correlation analysis
NeuroImage
(2010) - et al.
Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD
Neurobiology of Aging
(2007) - et al.
The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia
Neurobiology of Aging
(2003) - et al.
Frontotemporal dementia as a neural system disease
Neurobiology of Aging
(2005) - et al.
Reading disorders in primary progressive aphasia: A behavioral and neuroimaging study
Neuropsychologia
(2009) - et al.
Atrophy progression in semantic dementia with asymmetric temporal involvement: A tensor-based morphometry study
Neurobiology of Aging
(2009) - et al.
A tensor based morphometry study of longitudinal gray matter contraction in FTD
NeuroImage
(2007) - et al.
Neural basis for sentence comprehension deficits in frontotemporal dementia
Brain and Language
(2003) - et al.
Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI
NeuroImage
(2008) - et al.
Decline of cerebral glucose metabolism in frontotemporal dementia: A longitudinal 18F-FDG-PET-study
Neurobiology of Aging
(2007)
Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study
Neurobiology of Aging
Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease
NeuroImage
Subcortical and deep cortical atrophy in frontotemporal lobar degeneration
Neurobiology of Aging
Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer’s disease
NeuroImage
Relationship between antisocial behavior and regional cerebral blood flow in frontotemporal dementia
NeuroImage
Non-fluent progressive aphasia: Cerebral metabolic patterns and brain reserve
Brain Research
Patterns of cortical thinning in Alzheimer’s disease and frontotemporal dementia
Neurobiology of Aging
Language networks in semantic dementia
Brain
Performance in specific language tasks correlates with regional volume changes in progressive aphasia
Cognitive and Behavioral Neurology
Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration
Archives of Neurology
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia
Archives of Neurology
Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia
Archives of Neurology
The neural correlates of verbal and nonverbal semantic processing deficits in neurodegenerative disease
Cognitive and Behavioral Neurology
Deformation-based morphometry reveals brain atrophy in frontotemporal dementia
Archives of Neurology
The clinical profile of right temporal lobe atrophy
Brain
Rates of global and regional cerebral atrophy in AD and frontotemporal dementia
Neurology
Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease
Annals of Neurology
Patterns of white matter atrophy in frontotemporal lobar degeneration
Archives of Neurology
Alzheimer’s disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data
Journal of Neurology, Neurosurgery & Psychiatry
Different regional patterns of cortical thinning in Alzheimer’s disease and frontotemporal dementia
Brain
In vivo amyloid imaging with PET in frontotemporal dementia
European Journal of Nuclear Medicine and Molecular Imaging
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease
Brain
Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
Neurology
Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration
Annals of Neurology
Differing patterns of temporal atrophy in Alzheimer’s disease and semantic dementia
Neurology
Measuring disease progression in frontotemporal lobar degeneration: A clinical and MRI study
Neurology
The logopenic/phonological variant of primary progressive aphasia
Neurology
Cognition and anatomy in three variants of primary progressive aphasia
Annals of Neurology
Classification of primary progressive aphasia and its variants
Neurology
Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: A case report
Neurocase
Anatomical correlates of early mutism in progressive nonfluent aphasia
Neurology
Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: Evidence from functional MRI
Proceedings of the National Academy of Sciences of the United States of America
Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: A prospective 18F-FDG-PET study
Dementia and Geriatric Cognitive Disorders
Biomarkers in frontotemporal lobar degeneration
Current Opinion in Neurology
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia
Archives of Neurology
TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions
Archives of Neurology
A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer’s disease using FDG-PET imaging
Statistics in Medicine
Clinicopathological correlates in frontotemporal dementia
Annals of Neurology
Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy
Brain
Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia
Neurology
Cited by (45)
Longitudinal changes in network homogeneity in presymptomatic C9orf72 mutation carriers
2021, Neurobiology of AgingWhat semantic dementia teaches us about the functional organization of the left posterior fusiform gyrus
2017, NeuropsychologiaCitation Excerpt :Language remains fluent and well-structured, without any phonological or grammatical errors, and only subtle abnormalities in the syntactic structure of speech have been reported (Meteyard and Patterson, 2009). SD is associated with predominant anterior temporal lobe atrophy, often bilateral but predominantly on the left side and affecting the temporal pole (Collins et al., 2017) as well as the lateral and ventral temporal surfaces (Agosta et al., 2012; Kumfor et al., 2016). These regions have been identified as making a critical contribution to semantic representations (Jackson et al., 2016; Jefferies, 2013; Rice et al., 2015; Wong and Gallate, 2012).
- 1
These authors contributed equally to this work.